On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for the drug exceeded the available...more
2/24/2025
/ Compliance ,
Enforcement Actions ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Life Sciences ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Regulatory Requirements ,
Supply Shortages ,
Telehealth
On December 11, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) published a Special Fraud Alert warning against suspect payment arrangements involving the Medicare Advantage (“MA”) program...more
12/18/2024
/ Anti-Kickback Statute ,
Brokers ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Enrollment ,
Fraud Alerts ,
Health Care Providers ,
Healthcare Fraud ,
Incentives ,
Marketing ,
Medicare ,
Medicare Advantage ,
Medicare Advantage Organizations (MAOs) ,
OIG
On January 5, 2023, the Federal Trade Commission (“FTC”) published a Notice of Proposed Rulemaking (“NPRM”) which would broadly prohibit companies from entering into or enforcing non-competition agreements or clauses (also...more
On July 11, Pennsylvania Governor Tom Wolf signed Senate Bill 818 (“SB 818”) into law, which amends the Health Care Facilities Act to expand the number of procedures that may be performed in an ambulatory surgery center...more